Last reviewed · How we verify

NCT04824495

Evaluation of Inflammatory Cytokines During COVID-19

Status unknown Last updated 6 April 2021
What this trial tests

trial testing Blood sample in Covid19 in 100 participants. Status unknown.

Timeline
7 January 2021
Primary endpoint
31 August 2021
31 December 2021

Quick facts

Lead sponsorUniversity of Vienna
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date7 January 2021
Primary completion31 August 2021
Estimated completion31 December 2021
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

University of Vienna

Who can join

18 and older, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate pro-inflammatory cytokines as well as microvesicles during the course of SARS-CoV2 infection in the context of clinical parameters.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Impact of heated tobacco products on biomarkers of potential harm and adverse events: a systematic review and meta-analysis.
    Braznell S, Dance S, Hartmann-Boyce J, Gilmore A. · · 2026 · cited 3× · PMID 40300839 · DOI 10.1136/tc-2024-059000
  2. Vascular Stress Markers Following Inhalation of Heated Tobacco Products: A Study on Extracellular Vesicles.
    Antoniewicz L, Melnikov G, Lyytinen G, Blomberg A, et al · · 2025 · cited 3× · PMID 39472409 · DOI 10.1007/s12012-024-09934-6
  3. Vascular Stress Markers Following Inhalation of Heated Tobacco Products: A study on Extracellular Vesicles
    Antoniewicz L, Melnikov G, Lyytinen G, Blomberg A, et al · · 2024 · DOI 10.21203/rs.3.rs-4621527/v1

Verify or expand the search:

Other trials of Blood sample

Trials testing the same drug.

Other recruiting trials for Covid19

Currently open trials in the same condition.

Other University of Vienna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04824495.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing